Delivery Order SPE2DB22D1103-SPE2DB25FTAQ4

Award Date 10/18/24
Potential Completion Date 10/21/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of azathioprine 50 mg tablets. The contract has a ceiling value of $1,770.25 and a completion date of January 4, 2024. It is a firm-fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,686,970 Azathioprine 50 mg tablets. The firm fixed-price contract, valued at $1,472.68, has an ultimate completion date of January 24, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Azathioprine 50mg tablets for a total ceiling value of $1,308.06. The contract is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 1, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,040,915 units of the generic medication Azathioprine 50 mg tablets. The $2,055.74 firm fixed-price contract has an ultimate completion date of February 24, 2023. The contract is not designated as a set-aside. As an Indefinite Delivery Contract (IDC) holder with the DLA Troop Support Medical worth $999,999,999, AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The $2,389.84 firm fixed price contract has an ultimate completion date of July 30, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,000.79 firm fixed-price contract is for the supply of 4,567,522,925 tablets of the generic drug Azathioprine 50 mg. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,724.08, is for the delivery of 4,561,708,633 units of the medication Azathioprine 50 mg tablets, with a completion date of August 7, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559465323 - AZATHIOPRINE 50 MG TABLET 100S. The contract has a ceiling value of $6,334.16 and a completion date of December 29, 2022. It is a Firm Fixed Price contract and was not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth $999,999,999 with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,723,966 tablets of the medication azathioprine 50 mg. The contract has a firm fixed price of $1,335.54 and a completion date of July 8, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,609.98 firm fixed-price contract is for the delivery of Azathioprine 50 mg tablets. The contract has an ultimate completion date of September 12, 2024. Amerisourcebergen has been awarded numerous federal contracts to supply a wide range of pharmaceutical products and medical supplies to government agencies, including the DLA Troop...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTAQ4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Azathioprine 50 mg tablets. The contract has a ceiling value of $7,552.83 and runs through October 2024. It is a firm fixed-price contract, with no set-aside designation indicated.

AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company additionally maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 1/17/25, 9:24 AM